| Psoriasis |
1 |
1 |
| Cytokines |
0 |
0.39 |
| Genetics |
0 |
0.39 |
| Hospital |
0 |
0.39 |
| Allergy |
0 |
0.2 |
| Atopic Dermatitis |
0 |
0.2 |
| Bacterial Skin Infection |
0 |
0.2 |
| Body Mass Index |
0 |
0.2 |
| Diet |
0 |
0.2 |
| Dyslipidemia |
0 |
0.2 |
| Immunology |
0 |
0.2 |
| Immunosuppressive Therapy |
0 |
0.2 |
| Metabolism |
0 |
0.2 |
| Microbicides |
0 |
0.2 |
| Private Practice |
0 |
0.2 |
| Severity Index |
0 |
0.2 |
| Socioeconomics |
0 |
0.2 |
| Virology |
0 |
0.2 |
| HIV Infection |
0 |
0.12 |
| Dermatitis |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.07 |
| Tuberculosis |
0 |
0.07 |
| Biologic Therapy |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Obesity |
0 |
0.06 |
| Lipids Management |
0 |
0.05 |
| Hepatitis B Virus |
0 |
0.04 |
| Hepatitis C Virus |
0 |
0.04 |
| Metabolic Syndrome |
0 |
0.04 |
| Hypertension |
0 |
0.03 |
| Microbiome |
0 |
0.03 |
| Skin and Soft Tissue Infection |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |